Penicillin/ampicillin efficacy among children with severe pneumonia due to penicillin-resistant pneumococcus (MIC=4 microg ml(-1)).
Nascimento-Carvalho
Cristiana M
CM
Department of Paediatrics, School of Medicine, Federal University of Bahia, Salvador, Brazil.
Cardoso
Maria-Regina
MR
Faculty of Public Health, São Paulo University, São Paulo, Brazil.
Brandileone
Maria-Cristina
MC
Bacteriology Branch, Adolfo Lutz Institute, São Paulo, Brazil.
Ferrero
Fernando
F
Hospital de Niños Elizalde, Buenos Aires, Argentina.
Camargos
Paulo
P
Department of Pediatrics, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Berezin
Eitan
E
Santa Casa de São Paulo Medical School, São Paulo, Brazil.
Ruvinsky
Raul
R
Hospital Municipal Durand, Buenos Aires, Argentina.
Sant'Anna
Clemax
C
Martagão Gesteira Paediatric Institute, Rio de Janeiro, Brazil.
March
Maria-Fátima
MF
Martagão Gesteira Paediatric Institute, Rio de Janeiro, Brazil.
Feris-Iglesias
Jesus
J
Hospital Infantil Dr Robert Reid Cabral, Santo Domingo, Dominican Republic.
Maggi
Rubem
R
Instituto Materno Infantil de Pernambuco, Recife, Brazil.
Benguigui
Yehuda
Y
Child and Adolescent Health Unit, Pan American Health Organization, Washington, DC, USA.
D000667:Ampicillin / Q000008:administration & dosage*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D008826:Microbial Sensitivity Tests; D010403:Penicillin Resistance; D010406:Penicillins / Q000008:administration & dosage*; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy* / Q000382:microbiology*; D011379:Prognosis; D011446:Prospective Studies; D013296:Streptococcus pneumoniae / Q000187:drug effects / Q000302:isolation & purification; D017211:Treatment Failure
D000900:Anti-Bacterial Agents; D010406:Penicillins; D000667:Ampicillin